• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对日本复发性肝细胞癌患者再次肝切除术后手术结局的影响。

Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma.

作者信息

Utsunomiya Tohru, Okamoto Masahiro, Kameyama Toshihumi, Matsuyama Ayumi, Yamamoto Manabu, Fujiwara Megumu, Mori Masaki, Aimitsu Shiomi, Ishida Teruyoshi

机构信息

Department of Surgery, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima 730-8619, Japan.

出版信息

World J Gastroenterol. 2008 Mar 14;14(10):1553-8. doi: 10.3748/wjg.14.1553.

DOI:10.3748/wjg.14.1553
PMID:18330947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2693751/
Abstract

AIM

To evaluate the impact of obesity on the posto-perative outcome after hepatic resection in patients with hepatocellular carcinoma (HCC).

METHODS

Data from 328 consecutive patients with primary HCC and 60 patients with recurrent HCC were studied. We compared the surgical outcomes between the non-obese group (body mass index: BMI < 25 kg/m(2)) and the obese group (BMI > or = 25 kg/m(2)).

RESULTS

Following curative hepatectomy in patients with primary HCC, the incidence of postoperative complications and the long-term prognosis in the non-obese group (n = 240) were comparable to those in the obese group (n = 88). Among patients with recurrent HCC, the incidence of postoperative complications after repeat hepatectomy was not significantly different between the non-obese group (n = 44) and the obese group (n = 16). However, patients in the obese group showed a significantly poorer long-term prognosis than those in the non-obese group (P < 0.05, five-year survival rate; 51.9% and 92.0%, respectively).

CONCLUSION

Obesity alone may not have an adverse effect on the surgical outcomes of patients with primary HCC. However, greater caution seems to be required when planning a repeat hepatectomy for obese patients with recurrent HCC.

摘要

目的

评估肥胖对肝细胞癌(HCC)患者肝切除术后结局的影响。

方法

研究了328例连续性原发性HCC患者和60例复发性HCC患者的数据。我们比较了非肥胖组(体重指数:BMI < 25 kg/m²)和肥胖组(BMI ≥ 25 kg/m²)之间的手术结局。

结果

原发性HCC患者行根治性肝切除术后,非肥胖组(n = 240)的术后并发症发生率和长期预后与肥胖组(n = 88)相当。在复发性HCC患者中,非肥胖组(n = 44)和肥胖组(n = 16)再次肝切除术后的术后并发症发生率无显著差异。然而,肥胖组患者的长期预后明显比非肥胖组差(P < 0.05,五年生存率分别为51.9%和92.0%)。

结论

单纯肥胖可能不会对原发性HCC患者的手术结局产生不利影响。然而,对于复发性HCC的肥胖患者计划再次肝切除时似乎需要更加谨慎。

相似文献

1
Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma.肥胖对日本复发性肝细胞癌患者再次肝切除术后手术结局的影响。
World J Gastroenterol. 2008 Mar 14;14(10):1553-8. doi: 10.3748/wjg.14.1553.
2
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.中国单中心经验:复发性肝细胞癌患者再次肝切除的长期结果及复发类型分析和其预后。
Ann Surg Oncol. 2012 Aug;19(8):2515-25. doi: 10.1245/s10434-012-2269-7. Epub 2012 Mar 7.
3
Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.肝切除术后复发的肝细胞癌,再次肝切除术是最有效的治疗方法。
J Hepatobiliary Pancreat Surg. 2001;8(5):410-6. doi: 10.1007/s005340100002.
4
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.射频消融与再次切除治疗初始根治性切除后复发的≤5cm 肝细胞癌。
Eur Radiol. 2020 Nov;30(11):6357-6368. doi: 10.1007/s00330-020-06990-8. Epub 2020 Jun 11.
5
Hepatic cryosurgery for recurrent hepatocellular carcinoma after hepatectomy: a preliminary report.
J Surg Oncol. 1998 Jun;68(2):104-6. doi: 10.1002/(sici)1096-9098(199806)68:2<104::aid-jso6>3.0.co;2-a.
6
Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.复发性肝细胞癌的外科治疗:实现长期生存。
Ann Surg. 2021 Apr 1;273(4):792-799. doi: 10.1097/SLA.0000000000003358.
7
Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer.基于复发模式的复发性肝细胞癌的外科治疗:对于复发性多中心癌患者,再次肝切除或消融是不错的选择。
J Hepatobiliary Pancreat Surg. 2001;8(4):353-9. doi: 10.1007/s005340170008.
8
Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma.386例连续肝细胞癌患者肝切除术后的生存及复发情况。
J Am Coll Surg. 2000 Oct;191(4):381-8. doi: 10.1016/s1072-7515(00)00700-6.
9
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.复发性肝细胞癌患者再次肝切除术的选择标准。
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.
10
Influence of obesity on in-hospital and postoperative outcomes of hepatic resection for malignancy: a 10-year retrospective analysis from the US National Inpatient Sample.肥胖对恶性肿瘤肝切除术后住院及预后的影响:来自美国国家住院样本的10年回顾性分析
BMJ Open. 2019 Aug 27;9(8):e029823. doi: 10.1136/bmjopen-2019-029823.

引用本文的文献

1
The role of novel adipokines in hepatocellular carcinoma progression: a mini review.新型脂肪因子在肝细胞癌进展中的作用:一篇综述
Am J Cancer Res. 2024 Nov 15;14(11):5471-5485. doi: 10.62347/PZDM1736. eCollection 2024.
2
Obesity and lung cancer-a narrative review.肥胖与肺癌——一篇叙述性综述
J Thorac Dis. 2023 May 30;15(5):2806-2823. doi: 10.21037/jtd-22-1835. Epub 2023 May 8.
3
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.接受阿替利珠单抗联合贝伐珠单抗治疗的肝细胞癌患者体重指数的影响。
Hepatol Int. 2023 Aug;17(4):904-914. doi: 10.1007/s12072-023-10491-3. Epub 2023 Apr 1.
4
Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma.体重指数对接受腹腔镜肝切除术治疗肝细胞癌的老年患者的影响。
World J Gastrointest Surg. 2023 Jan 27;15(1):72-81. doi: 10.4240/wjgs.v15.i1.72.
5
Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies.探究肥胖悖论对肺癌及其他恶性肿瘤的影响。
Cancers (Basel). 2022 Mar 11;14(6):1440. doi: 10.3390/cancers14061440.
6
The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.血管包绕肿瘤簇对于复发性早期肝细胞癌治疗优化的预测价值。
Cancer Med. 2021 Aug;10(16):5466-5474. doi: 10.1002/cam4.4102. Epub 2021 Jul 1.
7
Laparoscopic hepatectomy reduces postoperative complications and hospital stay in overweight and obese patients.腹腔镜肝切除术可减少超重和肥胖患者的术后并发症及住院时间。
World J Gastrointest Surg. 2021 Jan 27;13(1):19-29. doi: 10.4240/wjgs.v13.i1.19.
8
Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation.糖尿病是乙型肝炎和丙型肝炎以外的肝细胞癌的一个独立的预后不良因素,与二氢嘧啶酶样 3 启动子甲基化相关。
Sci Rep. 2020 Jan 24;10(1):1156. doi: 10.1038/s41598-020-57883-1.
9
The impact of body mass index on perioperative outcomes after robotic liver resection.体重指数对机器人肝切除术后围手术期结局的影响。
J Robot Surg. 2020 Feb;14(1):41-46. doi: 10.1007/s11701-019-00923-4. Epub 2019 Feb 1.
10
Exploring the role of obesity and overweight in predicting postoperative outcome of abdominal surgery in a sub-Saharan African setting: a prospective cohort study.探索肥胖和超重对撒哈拉以南非洲地区腹部手术术后结局的预测作用:一项前瞻性队列研究。
BMC Res Notes. 2018 Oct 19;11(1):742. doi: 10.1186/s13104-018-3853-0.

本文引用的文献

1
Japan battles with obesity.日本面临肥胖问题。
Lancet. 2007 Feb 10;369(9560):451-2. doi: 10.1016/S0140-6736(07)60214-1.
2
Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).超重对胃癌手术并发症的影响:一项比较D2与扩大主动脉旁D3淋巴结清扫术(JCOG9501)的随机对照试验结果
Ann Surg Oncol. 2007 Feb;14(2):355-61. doi: 10.1245/s10434-006-9209-3. Epub 2006 Dec 5.
3
Molecular links between obesity and breast cancer.肥胖与乳腺癌之间的分子联系。
Endocr Relat Cancer. 2006 Jun;13(2):279-92. doi: 10.1677/erc.1.00729.
4
Obesity and cancer: the risks, science, and potential management strategies.肥胖与癌症:风险、科学及潜在管理策略
Oncology (Williston Park). 2005 Jun;19(7):871-81; discussion 881-2, 885-6.
5
Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study.超重对男性癌症发病率的影响,取决于癌症部位和组织学结果:韩国国民健康保险公团研究
J Clin Oncol. 2005 Jul 20;23(21):4742-54. doi: 10.1200/JCO.2005.11.726.
6
Obesity, fatty liver and liver cancer.肥胖、脂肪肝与肝癌。
Hepatobiliary Pancreat Dis Int. 2005 May;4(2):173-7.
7
Increasing body mass index in Japanese patients with gastric cancer.日本胃癌患者体重指数的增加
Gastric Cancer. 2005;8(1):39-41. doi: 10.1007/s10120-004-0304-5.
8
Liver resection for hepatocellular carcinoma in patients with cirrhosis.肝硬化患者肝细胞癌的肝切除术
Br J Surg. 2005 Mar;92(3):348-55. doi: 10.1002/bjs.4838.
9
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.非酒精性脂肪性肝炎:肝硬化、肝细胞癌及静止期非酒精性脂肪性肝炎。
J Gastroenterol. 2004 Dec;39(12):1215-8. doi: 10.1007/s00535-004-1475-x.
10
The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy.肥胖对腹腔镜左半结肠切除术技术可行性及术后结局的影响。
Ann Surg. 2005 Jan;241(1):69-76. doi: 10.1097/01.sla.0000150168.59592.b9.